Anhui Sunhere Pharmaceutical ExcipientsLtd Past Earnings Performance
Past criteria checks 4/6
Anhui Sunhere Pharmaceutical ExcipientsLtd has been growing earnings at an average annual rate of 16%, while the Pharmaceuticals industry saw earnings growing at 9.2% annually. Revenues have been growing at an average rate of 14.3% per year. Anhui Sunhere Pharmaceutical ExcipientsLtd's return on equity is 17%, and it has net margins of 19.5%.
Key information
16.0%
Earnings growth rate
16.0%
EPS growth rate
Pharmaceuticals Industry Growth | 10.9% |
Revenue growth rate | 14.3% |
Return on equity | 17.0% |
Net Margin | 19.5% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Anhui Sunhere Pharmaceutical ExcipientsLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 829 | 162 | 61 | 41 |
31 Dec 23 | 839 | 162 | 60 | 42 |
30 Sep 23 | 820 | 160 | 55 | 41 |
30 Jun 23 | 797 | 153 | 54 | 40 |
31 Mar 23 | 761 | 146 | 52 | 38 |
01 Jan 23 | 705 | 131 | 51 | 34 |
30 Sep 22 | 696 | 111 | 52 | 34 |
30 Jun 22 | 671 | 102 | 52 | 33 |
31 Mar 22 | 636 | 92 | 52 | 30 |
31 Dec 21 | 617 | 89 | 52 | 27 |
30 Sep 21 | 599 | 98 | 50 | 21 |
30 Jun 21 | 579 | 97 | 47 | 21 |
31 Mar 21 | 579 | 101 | 43 | 20 |
31 Dec 20 | 531 | 94 | 43 | 18 |
30 Sep 20 | 514 | 91 | 48 | 17 |
30 Jun 20 | 499 | 93 | 53 | 17 |
31 Mar 20 | 474 | 89 | 60 | 17 |
31 Dec 19 | 464 | 84 | 61 | 16 |
30 Sep 19 | 446 | 82 | 59 | 17 |
30 Jun 19 | 437 | 78 | 57 | 16 |
31 Mar 19 | 435 | 74 | 57 | 15 |
31 Dec 18 | 429 | 70 | 55 | 14 |
30 Sep 18 | 422 | 66 | 51 | 13 |
30 Jun 18 | 400 | 59 | 46 | 15 |
31 Mar 18 | 373 | 55 | 44 | 11 |
31 Dec 17 | 339 | 50 | 43 | 9 |
30 Sep 17 | 311 | 47 | 41 | 6 |
30 Jun 17 | 297 | 47 | 46 | 0 |
31 Mar 17 | 292 | 48 | 45 | 0 |
31 Dec 16 | 286 | 49 | 45 | 0 |
30 Sep 16 | 274 | 49 | 44 | 0 |
30 Jun 16 | 269 | 51 | 44 | 0 |
31 Mar 16 | 261 | 47 | 43 | 0 |
31 Dec 15 | 259 | 44 | 43 | 0 |
30 Sep 15 | 254 | 43 | 40 | 0 |
30 Jun 15 | 249 | 36 | 40 | 0 |
31 Mar 15 | 246 | 35 | 39 | 0 |
31 Dec 14 | 239 | 35 | 38 | 0 |
31 Dec 13 | 213 | 35 | 33 | 0 |
Quality Earnings: 300452 has high quality earnings.
Growing Profit Margin: 300452's current net profit margins (19.5%) are higher than last year (19.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300452's earnings have grown by 16% per year over the past 5 years.
Accelerating Growth: 300452's earnings growth over the past year (10.7%) is below its 5-year average (16% per year).
Earnings vs Industry: 300452 earnings growth over the past year (10.7%) exceeded the Pharmaceuticals industry -0.8%.
Return on Equity
High ROE: 300452's Return on Equity (17%) is considered low.